News - BIOQuébec

4 June 2026
Celebrating the Best in Canadian Biotech
BIOTECanada’s Gold Leaf Awards, established over 20 years ago, are considered a valuable national affirmation for…
Read more
4 June 2026
Upcoming classes and special offers from CASTL!
Build practical QC skills at…
Read more
28 May 2026
R&D Capital and the CQIB are joining forces to accelerate innovation in biotechnology in Quebec
R&D Capital and the CQIB are joining forces to accelerate innovation in biotechnology in Quebec…
Read more
26 May 2026
2025 Activity Report
In an industry where everything moves both quickly and slowly at the same time, one thing remains…
Read more
26 May 2026
BIOQuébec 2025 Annual Report
In an industry where everything moves both quickly and slowly at the same time, one thing remains…
Read more
26 May 2026
Call for Applications Now Open – ECBG Cohort 4
Applications are now open for the 4th cohort of the…
Read more

Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI® (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia

Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC), today announced that it has successfully completed …